Li Wei-Sin, Chen Yi-Chun, Kuo Shu-Fang, Chen Fang-Ju, Lee Chen-Hsiang
Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Department of Laboratory Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Front Microbiol. 2018 Jun 4;9:1196. doi: 10.3389/fmicb.2018.01196. eCollection 2018.
This study aimed to determine the predictors of persistent candidemia and examine the impact of biofilm formation by isolates in adult patients with candidemia. Of the adult patients with candidemia in Kaohsiung Chang Gung Memorial Hospital between January 2007 and December 2012, 68 case patients with persistent candidemia (repeated candidemia after a 3-day systemic antifungal therapy) and 68 control patients with non-persistent candidemia ( clearance from the bloodstream after a 3-day systemic antifungal therapy) were included based on propensity score matching and matching for the species isolated. Biofilm formation by the species was assessed using standard biomass assays. Presence of central venous catheters (CVCs) at diagnosis (adjusted odd ratio [AOR], 3.77; 95% confidence interval [CI], 1.09-13.00, = 0.04), infection with higher biofilm forming strains of species (AOR, 8.03; 95% CI, 2.50-25.81; < 0.01), and receipt of suboptimal fluconazole doses as initial therapy (AOR, 5.54; 95% CI, 1.53-20.10; < 0.01) were independently associated with persistent candidemia. Biofilm formation by , , and strains was significantly higher in the case patients than in the controls. There were no significant differences in the overall mortality and duration of hospitalization between the two groups. Our data suggest that, other than presence of retained CVCs and use of suboptimal doses of fluconazole, biofilm formation was highly associated with development of persistent candidemia.
本研究旨在确定持续性念珠菌血症的预测因素,并探讨念珠菌血症成年患者中分离株生物膜形成的影响。在2007年1月至2012年12月高雄长庚纪念医院的成年念珠菌血症患者中,基于倾向评分匹配和分离菌种匹配,纳入了68例持续性念珠菌血症患者(接受3天全身性抗真菌治疗后念珠菌血症复发)和68例非持续性念珠菌血症对照患者(接受3天全身性抗真菌治疗后血流中念珠菌清除)。使用标准生物量测定法评估分离菌种的生物膜形成。诊断时存在中心静脉导管(CVC)(调整后的优势比[AOR],3.77;95%置信区间[CI],1.09 - 13.00,P = 0.04)、感染生物膜形成能力较强的菌种(AOR,8.03;95%CI,2.50 - 25.81;P < 0.01)以及初始治疗接受次优剂量氟康唑(AOR,5.54;95%CI,1.53 - 20.10;P < 0.01)与持续性念珠菌血症独立相关。病例组中白色念珠菌、光滑念珠菌和热带念珠菌菌株的生物膜形成显著高于对照组。两组之间的总体死亡率和住院时间无显著差异。我们的数据表明,除了保留CVC和使用次优剂量氟康唑外,生物膜形成与持续性念珠菌血症的发生高度相关。